Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Lipum AB: BioStock: Lipum's CEO reflects on the year and comments on Eurostars funding

Lipum

2024 was an eventful year for Lipum, setting the stage for an equally exciting 2025. The year kicks off with the final report from the clinical phase I trial of the drug candidate SOL-116, followed by preparations for a phase II trial to demonstrate treatment efficacy in patients with rheumatoid arthritis. Additionally, Lipum recently secured funding from Eurostars for a project with Age Labs, focused on predicting which patients are most likely to respond to the treatment.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/12/lipums-ceo-reflects-on-the-year-and-comments-on-eurostars-funding/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.